Insulin and leptin levels in type 1 and type 2 diabetes patients with diabetes-associated osteoarthritis

Abstract

Background. Joint damage in patients with diabetes mellitus is a common complication and is associated with degenerative dystrophic changes in the periarticular structures. The purpose of our work was to study insulin and leptin hormone levels in patients with diabetic osteoarthritis and to investigate their possible influence on the development of this complication. Materials and methods. Seventy-seven patients were examined, they were divided into groups by the type of diabetes mellitus, the presence and severity of diabetic arthropathy. The content of insulin and leptin in the blood serum was determined by enzyme-linked immunosorbent assay. Results. Diabetic arthropathy was diagnosed in more than 70 % of patients. In persons with diabetic arthropathy, insulin levels were significantly elevated (for type 1 diabetes mellitus — by 38.5 %, for type 2 diabetes mellitus — by 55.6 %), as well as leptin content (for type 1 diabetes mellitus — by 43.8 %, for type 2 diabetes mellitus — by 53.7 %). There is a direct correlation between the severity of joint damage and the levels of insulin and leptin. The severity of arthropathy in patients with type 2 diabetes mellitus directly correlates with insulin resistance. Conclusions. Risk of developing arthropathy in type 1 diabetes mellitus with elevated insulin levels is increased by 3.8 times, with elevated leptin content — by 1.3 times, in patients with type 2 diabetes mellitus — by 2.6 and 1.2 times, respectively. For this sample, it was found that the development of arthropathy does not depend on the type of diabetes mellitus. In women with type 2 diabetes, the risk of developing arthropathy is 6.4-time higher than in men. Thus, an increased insulin and leptin levels can be markers of the presence and progression of arthropathy in patients with diabetes mellitus.

Authors and Affiliations

V. L. Orlenko, M. D. Tronko, O. T. Yelizarova

Keywords

Related Articles

Functional Foods in Complex Treatment of Patients with Metabolic Syndrome

Functional foods are intended for a systematic daily consumption and have a regulating effect on physiological functions, biochemical reactions and psychosocial behavior due to the normalization of microecological status...

Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus

Background. The current task of treating patients with type 2 diabetes mellitus and dyslipoproteinemia is the analysis of efficiency of the combination of standard hypoglycemic agents with phytotherapeutic drugs, but inf...

Lifestyle modification and dietary nutrition in patients with arterial hypertension and diabetes mellitus: recommendations of European consensus and the facts of life (literature review)

The review presents data from foreign and the national literature, world consensus recommendations 2016–2018 on the features of lifestyle modification, correction of alcohol consumption, smoking cessation, increased phys...

Hormonal and Biochemical Characteristic of Patients with Ischemic Heart Disease and Adult Growth Hormone Deficiency

In this article the authors analyzed the results of examination of 21 adult patients with ischemic heart disease against adult growth hormone deficiency. The decreasing of mean levels of growth hormone, LH in men and FSH...

Features of Clinical Course and Diagnosis of Patients with Family History of Non-Functioning Pituitary Adenomas

The study of the incidence of non-functioning pituitary adenomas (NFPA) among relatives is important for the choice of strategy and tactics of treatment of these patients, for the development of methods for predicting th...

Download PDF file
  • EP ID EP605103
  • DOI 10.22141/2224-0721.15.2.2019.166096
  • Views 60
  • Downloads 0

How To Cite

V. L. Orlenko, M. D. Tronko, O. T. Yelizarova (2019). Insulin and leptin levels in type 1 and type 2 diabetes patients with diabetes-associated osteoarthritis. Міжнародний ендокринологічний журнал, 15(2), 80-87. https://europub.co.uk/articles/-A-605103